Les rapports de cas

Midostaurin combined with CPX-351 (Vyxeos) appears safe for induction in FLT3 mutated acute myeloid leukemia

• Ramzi Abboud, Kristan M. Augustin, Matthew J. Walter, Camille N. Abboud, John S. Welch*